Adolescent Suicidality and Depression, Premenstrual Dysphoric Disorder, and Safety Issues Related to Ketamine and Esketamine Treatment
Author:
- 1 October 2025
- journal article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 182 (10) , 889-891
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- What's Behind the Increased Risk of Suicidal Behavior in Black Girls?American Journal of Psychiatry, 2025
- Toward Precision Reproductive Psychiatry: A Call for Targeted, Transdiagnostic Approaches to Premenstrual DisordersAmerican Journal of Psychiatry, 2025
- Neural Predictors of Risk for Developing a Depressive Disorder: Specificity, Generalizability, and Developmental TimingAmerican Journal of Psychiatry, 2025
- Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of FindingsAmerican Journal of Psychiatry, 2025
- Ketamine for Depression, but at What Cost? A Review of Ketamine’s Neurotoxic Effects From Preclinical and Human StudiesAmerican Journal of Psychiatry, 2025
- Real-World Safety of Esketamine Nasal Spray: A Comprehensive Analysis Almost 5 Years After First ApprovalAmerican Journal of Psychiatry, 2025
- Prevalence of Suicidal Ideation and Suicide Attempts by Race and Gender in Three Large U.S. Adolescent CohortsAmerican Journal of Psychiatry, 2025
- Prospective Associations Between Structural Brain Development and Onset of Depressive Disorder During Adolescence and Emerging AdulthoodAmerican Journal of Psychiatry, 2025
- National Trends in Suicidal Thoughts and Suicide Attempts Among High School Students in the United StatesAmerican Journal of Psychiatry, 2025
- Differential Behavioral Effects of Gonadal Steroids in Women with and in Those without Premenstrual SyndromeNew England Journal of Medicine, 1998